Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

The shampoo with Urtica urens L. extract reduced hair loss and didn't irritate the skin.

The shampoo with Urtica urens L. extract effectively reduces hair loss by over 50% without causing skin irritation.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.

Upadacitinib effectively treats psoriasis and lichen planus together.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Isoalantolactone promotes hair growth by activating specific cell pathways.

Combining ciprofloxacin with other treatments may improve its effectiveness against resistant bacteria.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Nano-phytopharmaceuticals show promise but need more research for safe, effective use in treating certain disorders.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

The gel shows strong potential for effectively treating pressure ulcers.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Nettle contains quercetin, a promising antioxidant and anti-aging agent.